3 Minute Read
Updates on US Territory Enrollment Updates, Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and its Relevance to FSS Agreements, and State Price Transparency Reporting Updates.
6 Minute Read
Updates on 340B Contract Pharmacy Restriction Updates, M&A and Venture Capital Funding in Biotech, and Stricter Accelerated Approval Criteria Proposed for FDA.
5 Minute Read
Updates on MDRP NOTICE Release No. 117, Inflation Reduction Act, and Operationalizing Medicare Inflationary Rebates.
5 Minute Read
Updates on two significant regulatory topics, including the FDA decision on orphan-drug exclusivity regulations and highlights from the Kaiser Family Foundation 2022 Employer Benefits Survey.
6 Minute Read
Updates on four significant regulatory topics, including the inflation reduction act impact on research and development, Office of Inspector General studies on Average Sales Price, and a shift of...
5 Minute Read
Updates on two significant regulatory topics, including value-based purchasing, interchangeabilty with biosimilars, and an end of 2022 roundup.
3 Minute Read
This is the first in a two-part blog series covering the ever-changing requirements by states as well as 2022 trends in Pricing Transparency Reporting.
5 Minute Read
Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.
3 Minute Read
Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.